Cited by 412Adipokines, Inflammation, and Metabolic DiseasesCytokine Signaling Pathways and InteractionsSphingolipid Metabolism and Signaling

Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase

Open access
Peraldi, Pascal, Hotamisligil, Gökhan S., Buurman, Wim A., White, Morris F., Spiegelman, Bruce M.·1996·Journal of Biological Chemistry

Abstract

Tumor necrosis factor (TNF)-alpha plays a central role in the state of insulin resistance associated with obesity. It has previously been shown that one important mechanism by which TNF-alpha interferes with insulin signaling is through the serine phosphorylation of insulin receptor substrate-1 (IRS-1), which can then function as an inhibitor of the tyrosine kinase activity of the insulin receptor (IR). However, the receptors and the signaling pathway used by TNF-alpha that mediate the inhibition of IR activity are unknown. We show here that human TNF-alpha, which binds only to the murine p55 TNF receptor (TNFR), is as effective at inhibiting insulin-dependent tyrosine phosphorylation of IR and IRS-1 in adipocytes and myeloid 32D cells as murine TNF-alpha, which binds to both p55 TNFR and p75 TNFR. Likewise, antibodies that are specific agonists for p55 TNFR or p75 TNFR demonstrate that stimulation of p55 TNFR is sufficient to inhibit insulin signaling, though a small effect can also be seen with antibodies to p75 TNFR. Exogenous sphingomyelinase and ceramides, known to be formed by activation of p55 TNFR, inhibit IR and IRS-1 tyrosine phosphorylation and convert IRS-1 into an inhibitor of IR tyrosine kinase in vitro. Myeloid 32D cells expressing IR and IRS-1 are sensitive to this inhibition, but cells expressing IR and IRS-2 are resistant, pointing to an important difference in the biological function between IRS-1 and IRS-2. These data strongly suggest that TNF-alpha inhibits insulin signaling via stimulation of p55 TNFR and sphingomyelinase activity, which results in the production of an inhibitory form of IRS-1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.271.22.13018

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TNF-α downregulates GLUT4 and inhibits insulin-dependent tyrosine phosphorylation of the insulin receptor and IRS-1 through ceramide production.

    “It downregulates the major insulin-responsive glucose transporter GLUT4 and inhibits insulin-dependent tyrosine phosphorylation of the insulin receptor and IRS-1 through ceramide production (70,71).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Olefsky, J., and Molina, J. (1990) in Diabetes Mellitus (Rifkin, H., and Porte, D. J., eds) pp. 121-153, Elsevier Science Publishing Co., Inc., New York
  2. Bennet, P. (1990) in Diabetes Mellitus (Rifkin, H., and Porte, J. D., eds) pp. 357-377, Elsevier Science Publishing Co., Inc., New York
  3. Hotamisligil, G. S., Murray, D. L., Choy, L. N., and Spiegelman, B. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4854 -4858
  4. Wang, L. M., Keegan, A. D., Li, W., Lienhard, G. E., Pacini, S., Gutkind, J. S., Myers, M. G., Sun, X. J., White, M. F., Aaronson, S. A., Paul, W. E., and Pierce, J. H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4032-4036
  5. Lewis, M., Tartaglia, L., Lee, A., Bennett, G., Rice, G., Wong, G. H. W., Chen, E., and Goeddel, D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 2830 -2834
  6. Sheperd, P., and Khan, B. (1993) in Insulin Resistance (Moller, D. E., ed) pp. 253-300, John Wiley & Sons, Inc., New York

Cited by

Sorted by citations

Authors
Peraldi, P., Hotamisligil, G. S., Buurman, W. A., White, M. F., & Spiegelman, B. M.
Affiliations
  • Harvard University (US)
  • Joslin Diabetes Center (US)
Corresponding author
Spiegelman, Bruce M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1996-05
Volume
271
Issue
22
Pages
13018-13022
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1971762417
Cited by
412
References
38
Citations by year
2026: 2 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 15 · 2020: 14 · 2019: 13 · 2018: 17 · 2017: 10 · 2016: 14 · 2015: 17 · 2014: 13 · 2013: 9 · 2012: 19
FWCI
19.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
TNF-α, insulin signaling, TNF receptor p55, TNF receptor 2, sphingomyelinase, ceramide, insulin receptor tyrosine phosphorylation, IRS-1, insulin receptor substrate 2, insulin resistance, obesity, adipocytes
MeSH terms
Animals, Cell Line, Ceramides, Enzyme Activation, Humans, Insulin, Phosphoproteins, Phosphorylation, Receptor, Insulin, Sphingomyelin Phosphodiesterase, Tumor Necrosis Factor-alpha, Tyrosine, Signal Transduction, Antigens, CD, 3T3 Cells, Adipocytes, Receptors, Tumor Necrosis Factor, Receptors, Tumor Necrosis Factor, Type I, Mice, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review